Evidence map›Paper›PMID 25309285›Full record

ArticleActa crystallographica. Section E, Structure reports online2014

Crystal structure of 1-(4-formyl-benzyl-idene)thio-semicarbazone.

Rosa Carballo, Arantxa Pino-Cuevas, Ezequiel M Vázquez-López

Abstract read
In one paragraph

Article in Acta crystallographica. Section E, Structure reports online, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Synthesis, crystal structure and Hirshfeld surface analysis of 4-{(1Acta crystallographica. Section E, Crystallographic communications · 2024
    Article
  2. Crystal structure of 4-[(E)-(2-carbamo-thio-ylhydrazinyl-idene)meth-yl]benzoic acid.Acta crystallographica. Section E, Crystallographic communications · 2015
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rosa CarballoDepartamento de Química Inorgánica, Facultade de Química, Edificio de Ciencias Experimentais, Universidade de Vigo, E-36310 Vigo, Galicia, Spain.
Arantxa Pino-CuevasDepartamento de Química Inorgánica, Facultade de Química, Edificio de Ciencias Experimentais, Universidade de Vigo, E-36310 Vigo, Galicia, Spain.
Ezequiel M Vázquez-LópezDepartamento de Química Inorgánica, Facultade de Química, Edificio de Ciencias Experimentais, Universidade de Vigo, E-36310 Vigo, Galicia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The asymmetric unit of the title compound, C9H9N3OS, contains two approximately planar mol-ecules (r.m.s. deviations for 14 non-H atoms = 0.094 and 0.045 Å), with different conformations. In one of them, the C=O group is syn to the S atom and in the other it is anti. Each mol-ecule features an intra-molecular N-H⋯N hydrogen bond, which generates an S(5) ring. In the crystal, mol-ecules are linked by N-H⋯O and N-H⋯S hydrogen bonds, generating discrete networks; the syn mol-ecules form [010] chains and the anti mol-ecules form (100) sheets.

Indexed as

crystal structurehydrogen bondsthio­semicarbazone

Identifiers

PMID25309285
PMCPMC4186181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.